Literature DB >> 26487650

Are we operating too late? Mortality Analysis and Stochastic Simulation of Costs Associated with Bariatric Surgery: Reconsidering the BMI Threshold.

Ashish C Sinha, Preet Mohinder Singh, Suneel Bhat.   

Abstract

BACKGROUND: Present guidelines recommend bariatric surgery at BMI ≥ 40 kg/m2 or BMI ≥ 35 kg/m2 with obesity-related morbidity.
METHODS: Evidence for cost and mortality/morbidity risk of bariatric surgery and obesity-related diseases was evaluated determining equivalency point of absolute incremental mortality risk by BMI and risks associated with bariatric surgery. A stochastic model was developed evaluating costs related to surgical procedure at a given BMI.
RESULTS: Bariatric surgery produces significant lifetime cost savings associated with diabetes, gallstones, hypertension, high cholesterol, colon cancer, heart disease, and stroke in men at BMI 30 kg/m2 for laparoscopic gastric bypass. For women, laparoscopic gastric bypass saves cost at BMI 32 kg/m2 and laparoscopic gastric banding at BMI 37 kg/m2. In white men, relative to single-year mortality risks by BMI, surgical intervention becomes risk-beneficial at BMI 25 kg/m2 for laparoscopic gastric banding, BMI 27 kg/m2 for laparoscopic gastric bypass procedure and open gastric banding, and BMI 37 kg/m2 for open gastric bypass. Risk benefit for African-American men by procedure occurs at BMI <25 kg/m2, BMI 27 kg/m2, and BMI 42 kg/m2, respectively. In white women, surgical intervention is beneficial at BMI 25.5 kg/m2 (laparoscopic gastric banding), BMI 28.5 kg/m2 (laparoscopic gastric bypass procedure), and BMI 45 kg/m2 (open gastric banding). Risk benefit for black women by procedure occurs at BMI 27.5 kg/m2, BMI 33.5 kg/m2, and BMI 50+ kg/m2, respectively.
CONCLUSION: Risk and cost benefit suggest surgical guidelines should be reconsidered. Threshold for bariatric surgery should be redefined to BMI 35 kg/m2 or BMI 30 kg/m2 with comorbidities.

Entities:  

Mesh:

Year:  2016        PMID: 26487650     DOI: 10.1007/s11695-015-1934-x

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   4.129


  54 in total

1.  Methods of calculating deaths attributable to obesity.

Authors:  Katherine M Flegal; Barry I Graubard; David F Williamson
Journal:  Am J Epidemiol       Date:  2004-08-15       Impact factor: 4.897

2.  What's the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes.

Authors:  J Zhang; K F Yu
Journal:  JAMA       Date:  1998-11-18       Impact factor: 56.272

3.  Cost of hypertension treatment.

Authors:  T W Odell; M C Gregory
Journal:  J Gen Intern Med       Date:  1995-12       Impact factor: 5.128

4.  Obesity and severe obesity forecasts through 2030.

Authors:  Eric A Finkelstein; Olga A Khavjou; Hope Thompson; Justin G Trogdon; Liping Pan; Bettylou Sherry; William Dietz
Journal:  Am J Prev Med       Date:  2012-06       Impact factor: 5.043

5.  Obesity management: what brings success?

Authors:  Ylva Trolle Lagerros; Stephan Rössner
Journal:  Therap Adv Gastroenterol       Date:  2013-01       Impact factor: 4.409

Review 6.  Osteoarthritis, inflammation and obesity.

Authors:  Francis Berenbaum; Florent Eymard; Xavier Houard
Journal:  Curr Opin Rheumatol       Date:  2013-01       Impact factor: 5.006

7.  The direct medical cost of type 2 diabetes.

Authors:  Michael Brandle; Honghong Zhou; Barbara R K Smith; Deanna Marriott; Ray Burke; Bahman P Tabaei; Morton B Brown; William H Herman
Journal:  Diabetes Care       Date:  2003-08       Impact factor: 19.112

8.  Cost effectiveness of thrombolytic therapy with tissue plasminogen activator as compared with streptokinase for acute myocardial infarction.

Authors:  D B Mark; M A Hlatky; R M Califf; C D Naylor; K L Lee; P W Armstrong; G Barbash; H White; M L Simoons; C L Nelson
Journal:  N Engl J Med       Date:  1995-05-25       Impact factor: 91.245

Review 9.  The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation.

Authors:  J Picot; J Jones; J L Colquitt; E Gospodarevskaya; E Loveman; L Baxter; A J Clegg
Journal:  Health Technol Assess       Date:  2009-09       Impact factor: 4.014

Review 10.  Bariatric surgery versus non-surgical treatment for obesity: a systematic review and meta-analysis of randomised controlled trials.

Authors:  Viktoria L Gloy; Matthias Briel; Deepak L Bhatt; Sangeeta R Kashyap; Philip R Schauer; Geltrude Mingrone; Heiner C Bucher; Alain J Nordmann
Journal:  BMJ       Date:  2013-10-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.